Haha, I don't think he does. That post was really just in

BioMarin's Latest Moves in Rare Disease Therapies Now here's a plot twist in the biotechnology landscape. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) just did what they do best—snagging rights to a promising enzyme therapy aimed at turning the tide for Fabry disease. In a deal that spoke volumes about their intentions, BioMarin is forking over a cool $70 million upfront...

SCI's Rough Ride: Investors Brace for Impact There's nothing like waking up to find the stock you were banking on took a nosedive while you were dreaming of dividends. Service Corporation International (NYSE: SCI) sure gave shareholders more of a nightmare than a dream, slashing its earnings forecast for 2026 and watching its stock crumble by about 11.6% on October 29....

Palmetto's New Release: Mergers & Acquisitions Focus Man, Palmetto Publishing just dropped a bombshell for home services aficionados with their latest M&A guide. Now, if you’re like me, swimming in stocks and always looking for that next big exit play, this one’s tailor-made for you. Mergers and acquisitions might not sound as flashy as the tech darlings or...

Welcome to Fear Incarnated Ah, Kansas City. More than just jazz and barbeque. You’ve got these infamous haunted houses that turn every horror flick into a mere Saturday morning cartoon. Enter Edge of Hell and Beast Haunted Attraction. Two horrifying museums of fear that somehow lure us like flies to sugar from miles away. What's the secret sauce? Well, that’s half the...

Crafting Stories with Precision: Cornue's Return In the world where Austin becomes a melting pot of ideas every spring, the return of David Cornue to SXSW casts a familiar, yet electrifying spark. This best-selling author and television whiz is slated to share his story magic at two workshops: one in the Lifestyle track and the other in the Film & TV track. Folks on-site...

Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...

Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....

Skechers Shareholders Stirring Over Lawsuit A fresh wave of legal antics is crashing at the shores of Skechers U.S.A., Inc. (NYSE: SKX) as frustrated shareholders mobilize against the footwear juggernaut. We're talking about a class action lawsuit here, folks, aimed at shaking down some clarity—or maybe just some cold, hard cash—from this bruiser over some sketchy...

Strategic Financial Move for OPC Energy Here's the scoop from the powerhouse behind some major U.S. electricity moves: OPC Energy and its subsidiary CPV nailed down a hefty $825 million financing package for the Shore and Maryland power plants. This isn’t just any old financial shuffle. Nope, they've hammered out an all-in-one refinancing deal that's setting the stage...

What's Cooking at wagamama with mamago? Here comes wagamama, striding into the American dining scene with that familiar bold Pan-Asian flair, now offering more than just a seat at their tables. The fresh move to a direct-to-door model dubbed ‘mamago’ ushers in an era where their signature dishes don't just seduce your taste buds at their restaurants. Nope, they are...

United Community Banks, Inc. Declares Quarterly Cash Dividend United Community Banks, Inc. (NYSE: UCB) has made an exciting announcement regarding its preferred stock dividends, affirming its dedication to rewarding shareholders. The Board of Directors has approved a quarterly cash dividend set at $429.6875 per share. This translates to $0.4296875 for each depositary...

Tempest Therapeutics Advances Amezalpat in Pivotal Trial Tempest Therapeutics, Inc. (Nasdaq: TPST) is thrilled to announce a major step forward in the fight against hepatocellular carcinoma (HCC), having received approval from China’s National Medical Products Administration (NMPA) to initiate a pivotal trial. This trial aims to evaluate the efficacy of amezalpat...

Overview of the Hydrophilic Coating Market Growth The hydrophilic coating market is on a remarkable trajectory, with projections indicating a growth from USD 16.59 billion in 2023 to USD 27.23 billion by 2032, translating to a compound annual growth rate (CAGR) of 5.66% during this period. This surge is largely driven by advancements in biomedical technology and an...

Counterweight Market Overview and Projected Growth The counterweight market is witnessing accelerated expansion, expected to reach approximately USD 6.1 billion by the year 2031. With a robust growth rate of around 4.9% during the forecast period, this sector is driven by the increasing demand across a wide range of applications. From elevators and forklifts to cranes and...

VerticalScope Prepares for 2024 Financial Results Announcement VerticalScope Holdings Inc. (TSX: FORA; OTCQX: VFORF) is gearing up to unveil its fourth quarter and full year financial results for 2024. This announcement is eagerly awaited by investors and community members alike, as it reflects the company's performance and growth in the digital enthusiast platform space....